Anti-thymoglobulin (ATG) treatment does not reverse type 1 diabetes in the acute virally induced rat insulin promoter-lymphocytic choriomeningitis virus (RIP-LCMV) model

Clinical and Experimental Immunology

Volumn 163, Issue 3, 2011, Pages 375-380

  Bresson, D ^a   Von Herrath, M G ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Anti thymoglobulin; Autoimmunity; Regulatory T cells; RIP LCMV mice; Type 1 diabetes

Indexed keywords

GLYCOPROTEIN; THYMOCYTE ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4 CD8 RATIO; CD4+ CD25+ T LYMPHOCYTE; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; RAT INSULIN PROMOTER LYMPHOCYTIC CHORIOMENINGITIS VIRUS MOUSE; VIRAL CLEARANCE;

ANIMALS; ANTILYMPHOCYTE SERUM; BLOOD GLUCOSE; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; INSULIN; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KINETICS; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROMOTER REGIONS, GENETIC; RATS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TREATMENT OUTCOME; VIRAL LOAD;

EID: 79551698801     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04304.x     Document Type: Article

References (15)

1. Shoda LK, Young DL, Ramanujan S etal. A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity 2005; 23:115-26.
2. Roep BO, Atkinson M, von Herrath M. Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes. Nat Rev Immunol 2004; 4:989-97.
3. von Herrath MG, Dockter J, Oldstone MB. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1994; 1:231-42.
4. von Herrath MG, Coon B, Wolfe T, Chatenoud L. Nonmitogenic CD3 antibody reverses virally induced (rat insulin promoter-lymphocytic choriomeningitis virus) autoimmune diabetes without impeding viral clearance. J Immunol 2002; 168:933-41.
5. Simon G, Parker M, Ramiya V etal. Murine antithymocyte globulin therapy alters disease progression in NOD mice by a time-dependent induction of immunoregulation. Diabetes 2008; 57:405-14.
6. McCausland MM, Crotty S. Quantitative PCR technique for detecting lymphocytic choriomeningitis virus in vivo. J Virol Methods 2008; 147:167-76.
7. Holz A, Dyrberg T, Hagopian W, Homann D, von Herrath M, Oldstone MB. Neither B lymphocytes nor antibodies directed against self antigens of the islets of Langerhans are required for development of virus-induced autoimmune diabetes. J Immunol 2000; 165:5945-53.
8. Bresson D, von Herrath M. Moving towards efficient therapies in type 1 diabetes: to combine or not to combine? Autoimmun Rev 2007; 6:315-22.
9. Chatenoud L, Thervet E, Primo J, Anti BJF. CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci USA 1994; 91:123-7.
10. Maki T, Ichikawa T, Blanco R, Porter J. Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum. Proc Natl Acad Sci USA 1992; 89:3434-8.
11. Ogawa N, Minamimura K, Kodaka T, Maki T. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes. J Autoimmun 2006; 26:225-31.
12. Eisenbarth GS, Srikanta S, Jackson R etal. Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus. Diabetes Res 1985; 2:271-6.
13. Bellin MD, Kandaswamy R, Parkey J etal. Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes. Am J Transplant 2008; 8:2463-70.
14. Hilbrands R, Huurman VA, Gillard P etal. Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients. Diabetes 2009; 58:2267-76.
15. Anderson MS, Bluestone JA. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 2005; 23:447-85.